Answers are grounded in this paper and cite their sources.
Osteoarthritis (OA) is a common degenerative joint disease with limited disease-modifying pharmacological options. Ginger (Zingiber officinale) is a food-medicine homology botanical with reported anti-inflammatory and analgesic properties, but its systems-level mechanisms in OA remain incompletely defined. This study integrated phenotype-curated transcriptomic analysis, network pharmacology, molecular docking and molecular dynamics (MD) simulation to prioritize potential ginger-related mechanisms in OA. Three human synovial GEO datasets (GSE206848, GSE55235 and GSE82107) were curated to exclude rheumatoid arthritis samples, yielding 24 non-OA controls and 27 OA samples. Differential expression was estimated using a linear model with dataset source as a covariate. Ginger constituents were screened by SwissADME, targets were predicted by SwissTargetPrediction, OA targets were collected from GeneCards, OMIM, CTD and TTD, and target-overlap enrichment was assessed by hypergeometric and Fisher exact tests. The transcriptomic analysis identified 164 OA-related DEGs, including 111 upregulated and 53 downregulated genes in OA. Network pharmacology identified 358 ginger-OA shared targets (hypergeometric P = 3.06 ×10^-72; Fisher odds ratio = 3.89), high-confidence STRING network-central candidates including TP53, SRC, AKT1, PIK3R1, PIK3CA and STAT3, and enriched pathways including TNF, PI3K-Akt, MAPK, HIF-1 and IL-17 signaling. Molecular docking suggested favorable binding of cubebin to FBP1, MMP1, MMP9 and MMP13. A 100-ns MD analysis of the cubebin-MMP13 system indicated a stable protein framework with ligand mobility. These findings prioritize ginger constituents as multi-target candidates related to OA inflammation, metabolic adaptation and matrix remodeling, and provide testable hypotheses for future experimental validation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: